Furthermore, device use within the GLP-1 using population declined only slightly, so that the overall impact on device use was less than 1%: While GLP-1s have been available for over 20 years, what has captured analysts attention over the past quarter are the dramatic increases in the percentage of body weight lost
This slow escalation minimizes gastrointestinal side effects and gives your body time to adjust
Aydin O, Ellidag HY, Eren E, Kurtulus F, Yaman A, Yilmaz N
Its during these dose increases that the body is working hardest to adjust, making nausea more prevalent
Overall, about one in five (22%) adults who are not currently taking GLP-1 drugs (88% of the public) say they would be interested in taking a GLP-1 drug to lose weight, including just 7% who say they would be very interested. This rises to four in ten (43%) among adults who are not currently taking a GLP-1 but report being diagnosed as overweight or obese in the past five years, and about one in four (27%) among those who say they have been diagnosed with diabetes or heart disease